Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
17 hedge funds and large institutions have $23.5M invested in Alpine Immune Sciences Inc in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
11% less funds holding
Funds holding: 19 → 17 (-2)
27% less capital invested
Capital invested by funds: $32.3M → $23.5M (-$8.86M)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$16.6K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$15.9K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$9.63K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$81 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$956K |
| 2 |
HP
Hikari Power
Tokyo,
Japan
|
-$55.1K |
| 3 |
DS
DRW Securities
Chicago,
Illinois
|
-$38K |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$18K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4K |
ALPN Hedge Fund Activity: Q1 2020 in Review
17 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q1 2020, worth a combined $23.5M — down 27% from $32.3M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ALPN and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, adding an estimated $16.6K. The largest seller was Deerfield Management, exiting entirely with an estimated $956K sold.
- 17 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q1 2020, down from 19 in Q4 2019.
- Funds reported $23.5M of Alpine Immune Sciences Inc stock for Q1 2020, down 27% quarter-over-quarter.
- 2 funds opened new Alpine Immune Sciences Inc positions in Q1 2020 and 4 closed out, a net change of -2 holders.
- The largest Alpine Immune Sciences Inc buyer in Q1 2020 was Renaissance Technologies, an estimated $16.6K added.
- The largest Alpine Immune Sciences Inc seller in Q1 2020 was Deerfield Management, an estimated $956K sold.
Based on aggregated 13F filings for Q1 2020.